Phase I/II Study of Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 30 Jun 2014
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Gemcitabine
- Indications Biliary cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Feb 2013 Planned end date changed from 1 Nov 2015 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 07 Feb 2011 New trial record